Based on its long lasting expertise in using NGS technologies, the CCG has been selected as a major production site of the WGGC. The additional funding provided by the DFG has been used not only to reach a competitive level of capacity, throughput and cost effectiveness but also to further expand CCG’s wide portfolio of all kinds of NGS applications, including single-cell genomics. Special research areas comprise cancer genomics, neuro- and nephrogenetics, plant genomics, RNA biology and method development  (cfDNA and ultra-low-input protocols).

WGGC Cologne Speaker - Prof. Dr. Dr. Michal R. Schweiger

WGGC Core Facility Leader - Dr. Kerstin Becker

Terms of use are available here (German only).